Literature DB >> 11375408

Can VEGF reverse diabetic neuropathy in human subjects?

A Veves1, G L King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11375408      PMCID： PMC209306          DOI： 10.1172/JCI13038

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

1.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy.

Authors:  P Schratzberger; G Schratzberger; M Silver; C Curry; M Kearney; M Magner; J Alroy; L S Adelman; D H Weinberg; A H Ropper; J M Isner
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

3.  Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

Authors:  S C Apfel; S Schwartz; B T Adornato; R Freeman; V Biton; M Rendell; A Vinik; M Giuliani; J C Stevens; R Barbano; P J Dyck
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

4.  Local human sural nerve blood flow in diabetic and other polyneuropathies.

Authors:  M Theriault; J Dort; G Sutherland; D W Zochodne
Journal:  Brain       Date:  1997-07       Impact factor: 13.501

5.  Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.

Authors:  N E Cameron; M A Cotter
Journal:  Diabetes       Date:  1997-09       Impact factor: 9.461

Review 6.  Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.

Authors:  E Duh; L P Aiello
Journal:  Diabetes       Date:  1999-10       Impact factor: 9.461

Review 7.  Vascular factors in diabetic neuropathy.

Authors:  S Tesfaye; R Malik; J D Ward
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

8.  Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy.

Authors:  A A Sima; M Bouchier; H Christensen
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

9.  Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits.

Authors:  N E Cameron; M A Cotter; P A Low
Journal:  Am J Physiol       Date:  1991-07

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
View more
  18 in total

Review 1.  Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes.

Authors:  Martin Röhling; Alexander Strom; Gidon J Bönhof; Michael Roden; Dan Ziegler
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

2.  Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy.

Authors:  John Doupis; Thomas E Lyons; Szuhuei Wu; Charalambos Gnardellis; Thanh Dinh; Aristidis Veves
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

Review 3.  Mechanisms of disease: the oxidative stress theory of diabetic neuropathy.

Authors:  Claudia Figueroa-Romero; Mahdieh Sadidi; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

4.  Vascular endothelial growth factor gene transfer for diabetic polyneuropathy.

Authors:  John A Kessler
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 5.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

6.  PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.

Authors:  Mogher Khamaisi; Sayaka Katagiri; Hillary Keenan; Kyoungmin Park; Yasutaka Maeda; Qian Li; Weier Qi; Thomas Thomou; Danielle Eschuk; Ana Tellechea; Aris Veves; Chenyu Huang; Dennis Paul Orgill; Amy Wagers; George L King
Journal:  J Clin Invest       Date:  2016-01-25       Impact factor: 14.808

7.  Induction of vascular endothelial growth factor release by transcutaneous frequency modulated neural stimulation in diabetic polyneuropathy.

Authors:  M Bevilacqua; L J Dominguez; M Barrella; M Barbagallo
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 8.  Paracrine control of vascularization and neurogenesis by neurotrophins.

Authors:  Costanza Emanueli; Peter Schratzberger; Rudolf Kirchmair; Paolo Madeddu
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

9.  Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia.

Authors:  Andrei Anghel; Bogdan Mut-Vitcu; Lorand Savu; Catalin Marian; Edward Seclaman; Raluca Iman; Adriana-Maria Neghina; Stefan I Dragulescu
Journal:  Genomic Med       Date:  2007-05-25

10.  Ruboxistaurin for the treatment of diabetic peripheral neuropathy: a systematic review of randomized clinical trials.

Authors:  Dipika Bansal; Yogesh Badhan; Kapil Gudala; Fabrizio Schifano
Journal:  Diabetes Metab J       Date:  2013-10-17       Impact factor: 5.376
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.